(Q70649453)
Statements
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer (English)
S A Rosenberg
M T Lotze
J C Yang
S L Topalian
A E Chang
D J Schwartzentruber
P Aebersold
S Leitman
W M Linehan
1 April 1993